Pregled bibliografske jedinice broj: 1029115
Results of the pilot study on molecular characterization of MDR clinical Acinetobacter baumannii isolates from neighbouring countries
Results of the pilot study on molecular characterization of MDR clinical Acinetobacter baumannii isolates from neighbouring countries // CROCMID 2019 Book of abstracts / Baršić, Bruno ; Tambić Andrašević, Arjana (ur.).
Split: Hrvatski liječnički zbor, 2019. O-64, 2 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1029115 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Results of the pilot study on molecular characterization of MDR clinical Acinetobacter baumannii isolates from neighbouring countries
Autori
Goić Barišić, Ivana ; Kovačić, Ana ; Medić, Deana ; Jakovac, Sanja ; Petrović, Tanja ; Tonkić, Marija ; Novak, Anita ; Rubić, Žana ; Radić, Marina ; Hrenović, Jasna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
CROCMID 2019 Book of abstracts
/ Baršić, Bruno ; Tambić Andrašević, Arjana - Split : Hrvatski liječnički zbor, 2019
Skup
12. Hrvatski kongres kliničke mikrobiologije ; 9. Hrvatski kongres o infektivnim bolestima (CROCMID 2019)
Mjesto i datum
Split, Hrvatska, 24.10.2019. - 27.10.2019
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Acinetobacter baumannii, resistance, south-eastern Europe
Sažetak
Acinetobacter baumannii has emerged as one of the most common nosocomial pathogens worldwide. This organism mostly targets the susceptible immunocompromised patients in ICUs where natural barriers are breached by trauma, surgery or mechanical support ventilation. MDR clinical isolates represent a major problem in the epidemiological and therapeutic sense and challenge for clinicians. Surveillance of carbapenem resistant isolates (which are also multiresistant) of A. baumannii in Croatia is continually monitored since in the last decade the percentage of carbepenem resistant isolates reached 97%. In addition to Croatia, Bosnia and Herzegovina and Serbia also recorded a significant increase in the incidence and prevalence in carbapenem resistant clinically relevant isolates of A. baumannii. The aim of this pilot study was to compare the genotype resemblance and resistance mechanism of 12 isolates of carbapenem resistant A. baumannii collected from three different hospitals in neighbouring countries in region of south-eastern Europe. First results of pilot study were presented on 12th Symposium on the biology of Acinetobacter in Frankfurt during September 2019.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ IP-2014-09-5656
Ustanove:
Prirodoslovno-matematički fakultet, Zagreb,
Medicinski fakultet, Split
